Rocket Lab (NASDAQ:RKLB) Shares Up 2.8% – Here’s Why

Shares of Rocket Lab Corporation (NASDAQ:RKLB) traded up 2.8% during mid-day trading on Tuesday. The stock traded as high as $78.28 and last traded at $75.06. 26,821,828 shares changed hands during trading, an increase of 16% from the average daily volume of 23,092,809 shares. The stock had previously closed at $73.02.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Analysts remain optimistic about Rocket Lab’s long-term outlook. One analyst reiterated a price target implying substantial upside, while other recent targets range from $96 to $135. The bullish case depends on successful execution of the Neutron rocket and continued growth in launch and space-systems operations. Rocket Lab Fell Hard Over The Last 3 Months: Wall Street Pro Predicts It Doubles From Today
• Positive Sentiment: NASA’s potential bulk purchase of launches for its planned lunar-base program is supporting the investment case. Rocket Lab has been identified as a possible provider through its future Neutron rocket, although no final contract has been awarded. The company also has a growing launch backlog and recently highlighted opportunities tied to defense and satellite infrastructure. Rocket Lab Gets A Fresh Opening In NASA’s $30 Billion Moon Push
• Neutral Sentiment: Rocket Lab’s proposed Iridium acquisition could materially expand its satellite-network business and add Iridium’s recurring earnings. However, the transaction involves substantial new shares and financing complexity, leaving investors focused on closing and integration risks. Rocket Lab: Iridium Could Explode EBITDA, But A Wildcard Decides If It’s Worth It
• Negative Sentiment: A regulatory win for a competing satellite operator pressured the broader space group, adding sectorwide selling to Rocket Lab’s stock-specific concerns. AST SpaceMobile Sinks as Satellite Rival Clears Regulatory Hurdle
• Negative Sentiment: Investors remain concerned about dilution from the Iridium deal and repeated insider sales, including sales by senior executives. Rocket Lab also recently missed quarterly earnings-per-share estimates despite exceeding revenue expectations, while its negative earnings and high valuation leave little room for execution setbacks. Rocket Lab Slides as Investors Weigh Iridium Deal Financing and Insider Sale Overhang

Analyst Ratings Changes

RKLB has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a report on Friday, July 17th. Berenberg Bank assumed coverage on Rocket Lab in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $83.00 price objective on the stock. Citigroup assumed coverage on shares of Rocket Lab in a research report on Thursday, October 1st. They set a “buy” rating and a $105.00 target price on the stock. KeyCorp restated an “overweight” rating on shares of Rocket Lab in a research report on Tuesday, August 11th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. Four analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $107.20.

Rocket Lab Stock Performance

The stock has a market cap of $40.72 billion, a P/E ratio of -252.46 and a beta of 2.93. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. The stock’s 50 day simple moving average is $70.38 and its two-hundred day simple moving average is $84.43.

Rocket Lab (NASDAQ:RKLB) last issued its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. As a group, research analysts forecast that Rocket Lab Corporation will post -0.2 EPS for the current year.

Insider Buying and Selling

In other news, SVP Arjun Kampani sold 6,034 shares of the stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $66.65, for a total transaction of $402,166.10. Following the completion of the transaction, the senior vice president directly owned 250,917 shares in the company, valued at $16,723,618.05. This represents a 2.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of Rocket Lab stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $1,048,001.13. Following the completion of the sale, the insider directly owned 458,924 shares in the company, valued at approximately $31,954,878.12. This represents a 3.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 400,749 shares of company stock valued at $26,964,474 over the last ninety days. Insiders own 8.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of RKLB. BlackRock Inc. acquired a new stake in shares of Rocket Lab in the 2nd quarter valued at approximately $4,124,970,000. Bank of New York Mellon Corp bought a new position in shares of Rocket Lab in the 2nd quarter valued at about $245,764,000. Bank of America Corp DE acquired a new position in shares of Rocket Lab during the 2nd quarter worth about $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Rocket Lab by 14.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer’s stock valued at $278,262,000 after purchasing an additional 352,094 shares during the period. Finally, Amundi lifted its stake in Rocket Lab by 22.2% in the 2nd quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after purchasing an additional 396,639 shares during the last quarter. 71.78% of the stock is currently owned by institutional investors.

About Rocket Lab

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.